Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
Clinical trial NCT06563245 · RECRUITING
Trial details
- NCT number
- NCT06563245
- Sponsor
- Children's Cancer Group, China
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-25
- Primary completion
- 2029-11-15
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.